title: Regression of an HCV-associated disseminated marginal zone lymphoma under IFN-free antiviral treatment.
authors: Département d'Hépatologie, Assistance Publique-Hôpitaux de Paris, Hôpital Cochin, Université Paris Descartes, Paris, France INSERM UMS20, Institut Pasteur, Paris, France.
authors: Philippe
authors: P
authors: Sultanik
authors: Département d'Hépatologie, Assistance Publique-Hôpitaux de Paris, Hôpital Cochin, Université Paris Descartes, Paris, France.
authors: Caroline
authors: C
authors: Klotz
authors: Institut Curie, Paris, France.
authors: Philippe
authors: P
authors: Brault
authors: Département d'Hépatologie, Assistance Publique-Hôpitaux de Paris, Hôpital Cochin, Université Paris Descartes, Paris, France INSERM UMS20, Institut Pasteur, Paris, France.
authors: Stanislas
authors: S
authors: Pol
authors: Département d'Hépatologie, Assistance Publique-Hôpitaux de Paris, Hôpital Cochin, Université Paris Descartes, Paris, France INSERM UMS20, Institut Pasteur, Paris, France.
authors: Vincent
authors: V
authors: Mallet
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D016174:Hepacivirus / Q000302:isolation & purification; D006526:Hepatitis C / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D018442:Lymphoma, B-Cell, Marginal Zone / Q000150:complications / Q000188:drug therapy* / Q000473:pathology / Q000821:virology*; D008875:Middle Aged; D012254:Ribavirin / Q000627:therapeutic use*; D000069474:Sofosbuvir; D014542:Uridine Monophosphate / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000998:Antiviral Agents; D012254:Ribavirin; D014542:Uridine Monophosphate; D000069474:Sofosbuvir